Synopsis
Synopsis
0
KDMF
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Aminazine
2. Chlorazine
3. Chlordelazine
4. Chlorpromazine
5. Contomin
6. Fenactil
7. Hydrochloride, Chlorpromazine
8. Largactil
9. Propaphenin
10. Thorazine
1. 69-09-0
2. Chlorpromazine Hcl
3. Sonazine
4. Chloractil
5. Klorproman
6. Klorpromex
7. Marazine
8. Norcozine
9. Promacid
10. Hebanil
11. Promapar
12. Hybernal
13. Lomazine
14. Neurazine
15. Plegomazin
16. Promachel
17. Promexin
18. Taroctyl
19. Tranzine
20. Hibernal
21. Unitensen
22. Nci-c05210
23. Chlorpromazine (hydrochloride)
24. Aminazin Monohydrochloride
25. Fenactil Monohydrochloride
26. Chloropromazine Monohydrochloride
27. Ampliactil Monohydrochloride
28. Hibanil
29. Chlorpromazinium Chloride
30. Chlorpromazine Monohydrochloride
31. [3-(2-chloro-10h-phenothiazin-10-yl)propyl]-dimethylamine Hydrochloride
32. Chloropromazine Hydrochloride
33. Propaphen
34. 10-(3-dimethylaminopropyl)-2-chlorophenothiazine Monohydrochloride
35. Thorazine Hydrochloride
36. 3-(2-chlorophenothiazin-10-yl)-n,n-dimethylpropan-1-amine;hydrochloride
37. 3-(2-chloro-10h-phenothiazin-10-yl)-n,n-dimethylpropan-1-amine Hydrochloride
38. Mls000069401
39. Chebi:3649
40. 2-chloro-10-(3-(dimethylamino)propyl)phenothiazine Monohydrochloride
41. 10h-phenothiazine-10-propanamine, 2-chloro-n,n-dimethyl-, Monohydrochloride
42. Nsc-17479
43. 9wp59609j6
44. 69-09-0 (hcl)
45. Aminazinum
46. Megatil
47. Smr000058254
48. 2-chloro-10-(3-dimethylaminopropyl)phenothiazine Hydrochloride
49. 4560 Rp Hydrochloride
50. Chlorpromazine, Hydrochloride
51. Contomin Hydrochloride
52. Megaphen Hydrochloride
53. Phenothiazine Hydrochloride
54. Largactil Monohydrochloride
55. Cpz (van)
56. Nsc17479
57. Ccris 6221
58. [3-(2-chloro-10h-phenothiazin-10-yl)propyl]dimethylamine Hydrochloride
59. Cas-69-09-0
60. Sr-01000000012
61. Einecs 200-701-3
62. Nsc 17479
63. Chloropromazin Hydrochloride
64. Largaktyl
65. Ai3-28023
66. Unii-9wp59609j6
67. Prestwick_58
68. Sonazine (tn)
69. Chlorpromazine Hydrochloride Intensol
70. Mfcd00012654
71. Chlorpromazine Chloride
72. Ac1lcwf1
73. Chlorpromazine Hydrochloride [usp:ban:jan]
74. Opera_id_1294
75. Dsstox_cid_4827
76. Chlorpromazini Hydrochloridum
77. Chembl1713
78. Dsstox_rid_77545
79. Dsstox_gsid_24827
80. Schembl41771
81. Mls001148603
82. Mls002222157
83. Chlorpromazin-d6 Hydrochloride
84. Dtxsid7024827
85. Hy-b0407a
86. Chlorpromazine Hydrochloride, 98%
87. Hms1568m09
88. Bcp30284
89. Tox21_300517
90. Tox21_500249
91. Nsc226514
92. S2456
93. Akos005111082
94. Phenothiazine, 2-chloro-10-(3-(dimethylamino)propyl)-, Monohydrochloride
95. Ccg-220064
96. Ccg-221553
97. Chlorpromazine-[13c,d3] Hydrochloride
98. Lp00249
99. Nc00552
100. 7-[diethylamino]coumarin-3-carbonylazide
101. Chlorpromazine Hydrochloride (jp17/usp)
102. Chlorpromazine Hydrochloride [mi]
103. Ncgc00024409-09
104. Ncgc00093711-01
105. Ncgc00093711-02
106. Ncgc00180973-01
107. Ncgc00254272-01
108. Ncgc00260934-01
109. Ac-10573
110. Chlorpromazine Hydrochloride [jan]
111. Ls-14587
112. Chlorpromazine Hydrochloride [mart.]
113. Chlorpromazine Hydrochloride [vandf]
114. C-165
115. Chlorpromazine Hydrochloride [usp-rs]
116. Chlorpromazine Hydrochloride [who-dd]
117. Chlorpromazine Hydrochloride [who-ip]
118. Chlorpromazine Hydrochloride, >=98% (tlc)
119. Eu-0100249
120. Ft-0623715
121. Ft-0665009
122. Sw196373-5
123. C 8138
124. C07952
125. Chlorpromazine, Hydrochloride - Cas 69-09-0
126. D00789
127. D89519
128. Mls-0090820.0001
129. Chlorpromazine Hydrochloride [green Book]
130. Wln: T C666 Bn Isj B3n1&1 Eg &gh
131. 012c654
132. Chlorpromazine Hydrochloride [ep Impurity]
133. Chlorpromazine Hydrochloride [ep Monograph]
134. Chlorpromazine Hydrochloride [orange Book]
135. Chlorpromazine Hydrochloride [usp Monograph]
136. Chlorpromazini Hydrochloridum [who-ip Latin]
137. Q-200842
138. Sr-01000000012-2
139. Sr-01000000012-9
140. Chlorpromazine Hydrochloride 100 Microg/ml In Methanol
141. Q27106159
142. Z1259155914
143. 2-chloro-10-(3-dimethylaminopropyl) Phenothiazine Hydrochloride
144. Chlorpromazine Hydrochloride, Meets Usp Testing Specifications
145. Chlorpromazine Hydrochloride, Vetranal(tm), Analytical Standard
146. 2-chloro-10-(3-dimethylaminopropyl)phenothiazine Monohydrochloride
147. 2-chloro-10-[3-(dimethylamino)-1-propyl]phenothiazine Hydrochloride
148. Chlorpromazine Hydrochloride 1.0 Mg/ml In Methanol (as Free Base)
149. 10h-phenothiazine-10-propanamine Hydrochloride, 2-chloro-n,n-dimethyl-
150. 3-(2-chlorophenothiazin-10-yl)-n,n-dimethylpropan-1-amine;hydrochloride.
151. Chlorpromazine Hydrochloride, European Pharmacopoeia (ep) Reference Standard
152. 10h-phenothiazine-10-propanamine, 2-chloro-n,n-dimethyl-, Hydrochloride (1:1)
153. Chlorpromazine Hydrochloride, United States Pharmacopeia (usp) Reference Standard
154. Chlorpromazine Hydrochloride Solution, 1.0 Mg/ml In Methanol (as Free Base), Ampule Of 1 Ml, Certified Reference Material
1. 2-chlorophenothiazine
Molecular Weight | 355.3 g/mol |
---|---|
Molecular Formula | C17H20Cl2N2S |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 3 |
Rotatable Bond Count | 4 |
Exact Mass | 354.0724252 g/mol |
Monoisotopic Mass | 354.0724252 g/mol |
Topological Polar Surface Area | 31.8 Ų |
Heavy Atom Count | 22 |
Formal Charge | 0 |
Complexity | 339 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
1 of 2 | |
---|---|
Drug Name | Chlorpromazine hydrochloride |
Drug Label | DESCRIPTION Chlorpromazine hydrochloride, a dimethylamine derivative of phenothiazine, has a chemical formula of 2-chloro-10-[3(-dimethylamino) propyl] phenothiazine monohydochloride. It is available in tablets for oral administration. It has the fol... |
Active Ingredient | Chlorpromazine hydrochloride |
Dosage Form | Injectable; Tablet |
Route | Injection; Oral |
Strength | 25mg/ml; 200mg; 100mg; 25mg; 50mg; 10mg |
Market Status | Prescription |
Company | Hikma Maple; Usl Pharma; Sandoz |
2 of 2 | |
---|---|
Drug Name | Chlorpromazine hydrochloride |
Drug Label | DESCRIPTION Chlorpromazine hydrochloride, a dimethylamine derivative of phenothiazine, has a chemical formula of 2-chloro-10-[3(-dimethylamino) propyl] phenothiazine monohydochloride. It is available in tablets for oral administration. It has the fol... |
Active Ingredient | Chlorpromazine hydrochloride |
Dosage Form | Injectable; Tablet |
Route | Injection; Oral |
Strength | 25mg/ml; 200mg; 100mg; 25mg; 50mg; 10mg |
Market Status | Prescription |
Company | Hikma Maple; Usl Pharma; Sandoz |
Antipsychotic Agents
Agents that control agitated psychotic behavior, alleviate acute psychotic states, reduce psychotic symptoms, and exert a quieting effect. They are used in SCHIZOPHRENIA; senile dementia; transient psychosis following surgery; or MYOCARDIAL INFARCTION; etc. These drugs are often referred to as neuroleptics alluding to the tendency to produce neurological side effects, but not all antipsychotics are likely to produce such effects. Many of these drugs may also be effective against nausea, emesis, and pruritus. (See all compounds classified as Antipsychotic Agents.)
Antiemetics
Drugs used to prevent NAUSEA or VOMITING. (See all compounds classified as Antiemetics.)
Dopamine Antagonists
Drugs that bind to but do not activate DOPAMINE RECEPTORS, thereby blocking the actions of dopamine or exogenous agonists. Many drugs used in the treatment of psychotic disorders (ANTIPSYCHOTIC AGENTS) are dopamine antagonists, although their therapeutic effects may be due to long-term adjustments of the brain rather than to the acute effects of blocking dopamine receptors. Dopamine antagonists have been used for several other clinical purposes including as ANTIEMETICS, in the treatment of Tourette syndrome, and for hiccup. Dopamine receptor blockade is associated with NEUROLEPTIC MALIGNANT SYNDROME. (See all compounds classified as Dopamine Antagonists.)
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
DRUG PRODUCT COMPOSITIONS
Related Excipient Companies
Dosage Form : Injectable / Parenteral
Grade : Parenteral
Brand Name : NaCl Multi-compendial Low...
Application : Parenteral
Excipient Details : A & C's Sodium Chloride multi-compendial low endotoxin is an excipient meeting USP-NF, EP, BP and JP monographs.
Pharmacopoeia Ref : Multi-compendial
Technical Specs : Low Endotoxin
Ingredient(s) : Sodium Chloride Excipient
Dosage Form : Gel
Grade : Parenteral, Topical
Brand Name : Polyethylene Glycol 200 N...
Application : Topical
Excipient Details : A & C's Polyethylene Glycol 200 is an excipient which meets the NF monograph.
Pharmacopoeia Ref : NF
Technical Specs : Polyethylene Glycol 200; Polyethylene Glycol 300; Polyethylene Glycol 400; Low Endotoxin
Ingredient(s) : polyethylene glycol
Dosage Form : Cream / Lotion / Ointment
Grade : Topical, Parenteral
Brand Name : Polyethylene Glycol 300 N...
Application : Topical
Excipient Details : A & C's Polyethylene Glycol 300 is an excipient which meets the NF monograph.
Dosage Form : Gel
Grade : Topical, Parenteral
Brand Name : Polyethylene Glycol 400
Application : Topical
Excipient Details : A&C's Polyethylene Glycol 400 USP-NF is a short chain non-ionic surfactant.
Pharmacopoeia Ref : Not Available
Technical Specs : Low Endotoxin
Ingredient(s) : polyethylene glycol
Dosage Form : Tablet
Grade : Topical and Oral
Brand Name : Polyethylene Glycol 400
Application : Controlled & Modified Release
Pharmacopoeia Ref : Not Available
Technical Specs : Not Available
Ingredient(s) : polyethylene glycol
Dosage Form : Injectable / Parenteral
Grade : Parenteral
Brand Name : Sodium Chloride USP
Application : Parenteral
Excipient Details : A & C's Sodium Chloride is an excipient meeting the USP monograph.
Dosage Form : Syrup
Grade : Oral
Brand Name : Sucrose Multi-Compendial
Application : Taste Masking
Excipient Details : A & C's Sucrose multi-compendial is a pharmaceutical excipient grade meeting the current specifications of USP-NF, EP and JP monographs.
Dosage Form : Tablet
Grade : Topical and Oral
Brand Name : Polyethylene Glycol 400
Application : Controlled & Modified Release
Pharmacopoeia Ref : Not Available
Technical Specs : Not Available
Ingredient(s) : polyethylene glycol
Dosage Form : Tablet
Grade : Oral
Application : Taste Masking
Excipient Details : F-Melt Type C is a pharmaceutical excipient used in oral dosage forms like orally disintegrating tablets, sachets, dispersible tablets, chewable tablets and sublingual tablets.
Pharmacopoeia Ref : Conforms to Japanese Pharmaceu...
Technical Specs : Not Available
Ingredient(s) : Crospovidone
Dosage Form : Orodispersible Tablet
Grade : Oral
Application : Disintegrants & Superdisintegrants
Excipient Details : F-Melt Type M is used in various dosage forms like orally disintegrating tablets (ODTs), sachets, dispersible tablets, chewable tablets and sublingual formulations.
Pharmacopoeia Ref : Conforms to Japanese Pharmaceu...
Technical Specs : Not Available
Ingredient(s) : Crospovidone
Dosage Form : Capsule
Grade : Oral
Application : Fillers, Diluents & Binders
Pharmacopoeia Ref : USP-NF, EP, BP, IP, JP, FCC
Technical Specs : PVP K-K-30/ K-17/ K19/ K25/ K90
Ingredient(s) : Povidone
Dosage Form : Capsule
Grade : Oral
Application : Solubilizers
Excipient Details : Super disintegrate, solublity enhancer, Suspension stabilizer, Complexing agent, Low peroxide content, Long term stability
Pharmacopoeia Ref : Not Available
Technical Specs : Crospovidone (Type-A/B)- USP-NF / Ph. Eur. / BP / IP
Ingredient(s) : Crospovidone
Dosage Form : Capsule
Grade : Oral
Application : Coating Systems & Additives
Excipient Details : Ready mix Film coating system for moisture sensitive APIs
Pharmacopoeia Ref : USP, EP, JP; Having US-DMF
Technical Specs : Moisture barrier film coating system
Ingredient(s) : Hydroxypropyl Methyl Cellulose
Dosage Form : Capsule
Grade : Oral
Application : Coating Systems & Additives
Excipient Details : Ready mix Non-Functional film coating system.
Pharmacopoeia Ref : USP, EP, JP; Having US-DMF
Technical Specs : Not Available
Ingredient(s) : Hydroxypropyl Methyl Cellulose
Dosage Form : Capsule
Grade : Oral
Application : Taste Masking
Excipient Details : Ready mix sugar coating system.
Pharmacopoeia Ref : USP, EP, JP & having US DMF
Technical Specs : Sprayable sugar coating system for solid oral dosage form
Ingredient(s) : Hydroxypropyl Methyl Cellulose
Excipients by Applications
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
53
PharmaCompass offers a list of Chlorpromazine Hydrochloride API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Chlorpromazine Hydrochloride manufacturer or Chlorpromazine Hydrochloride supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Chlorpromazine Hydrochloride manufacturer or Chlorpromazine Hydrochloride supplier.
PharmaCompass also assists you with knowing the Chlorpromazine Hydrochloride API Price utilized in the formulation of products. Chlorpromazine Hydrochloride API Price is not always fixed or binding as the Chlorpromazine Hydrochloride Price is obtained through a variety of data sources. The Chlorpromazine Hydrochloride Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A NCGC00024409-09 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of NCGC00024409-09, including repackagers and relabelers. The FDA regulates NCGC00024409-09 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. NCGC00024409-09 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of NCGC00024409-09 manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A NCGC00024409-09 supplier is an individual or a company that provides NCGC00024409-09 active pharmaceutical ingredient (API) or NCGC00024409-09 finished formulations upon request. The NCGC00024409-09 suppliers may include NCGC00024409-09 API manufacturers, exporters, distributors and traders.
click here to find a list of NCGC00024409-09 suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A NCGC00024409-09 DMF (Drug Master File) is a document detailing the whole manufacturing process of NCGC00024409-09 active pharmaceutical ingredient (API) in detail. Different forms of NCGC00024409-09 DMFs exist exist since differing nations have different regulations, such as NCGC00024409-09 USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A NCGC00024409-09 DMF submitted to regulatory agencies in the US is known as a USDMF. NCGC00024409-09 USDMF includes data on NCGC00024409-09's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The NCGC00024409-09 USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of NCGC00024409-09 suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The NCGC00024409-09 Drug Master File in Japan (NCGC00024409-09 JDMF) empowers NCGC00024409-09 API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the NCGC00024409-09 JDMF during the approval evaluation for pharmaceutical products. At the time of NCGC00024409-09 JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of NCGC00024409-09 suppliers with JDMF on PharmaCompass.
A NCGC00024409-09 CEP of the European Pharmacopoeia monograph is often referred to as a NCGC00024409-09 Certificate of Suitability (COS). The purpose of a NCGC00024409-09 CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of NCGC00024409-09 EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of NCGC00024409-09 to their clients by showing that a NCGC00024409-09 CEP has been issued for it. The manufacturer submits a NCGC00024409-09 CEP (COS) as part of the market authorization procedure, and it takes on the role of a NCGC00024409-09 CEP holder for the record. Additionally, the data presented in the NCGC00024409-09 CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the NCGC00024409-09 DMF.
A NCGC00024409-09 CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. NCGC00024409-09 CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of NCGC00024409-09 suppliers with CEP (COS) on PharmaCompass.
A NCGC00024409-09 written confirmation (NCGC00024409-09 WC) is an official document issued by a regulatory agency to a NCGC00024409-09 manufacturer, verifying that the manufacturing facility of a NCGC00024409-09 active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting NCGC00024409-09 APIs or NCGC00024409-09 finished pharmaceutical products to another nation, regulatory agencies frequently require a NCGC00024409-09 WC (written confirmation) as part of the regulatory process.
click here to find a list of NCGC00024409-09 suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing NCGC00024409-09 as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for NCGC00024409-09 API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture NCGC00024409-09 as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain NCGC00024409-09 and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a NCGC00024409-09 NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of NCGC00024409-09 suppliers with NDC on PharmaCompass.
NCGC00024409-09 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of NCGC00024409-09 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right NCGC00024409-09 GMP manufacturer or NCGC00024409-09 GMP API supplier for your needs.
A NCGC00024409-09 CoA (Certificate of Analysis) is a formal document that attests to NCGC00024409-09's compliance with NCGC00024409-09 specifications and serves as a tool for batch-level quality control.
NCGC00024409-09 CoA mostly includes findings from lab analyses of a specific batch. For each NCGC00024409-09 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
NCGC00024409-09 may be tested according to a variety of international standards, such as European Pharmacopoeia (NCGC00024409-09 EP), NCGC00024409-09 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (NCGC00024409-09 USP).